C.S. Cooper
Impact in
-
- Sarcoma Diagnosis and Treatment
-
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Carcinogens and Genotoxicity Assessment 5
- Oncology 4
- Cancer-related Molecular Pathways 4
- Co-authors
- Michael R. Stratton (4 shared papers)B.A. Gusterson (2 shared papers)Cyril Fisher (3 shared papers)Brian R. Reeves (2 shared papers)Marianne K. Oskarsson (2 shared papers)Peter L Lantos (1 shared paper)John L. Darling (1 shared paper)Sandra Gill (3 shared papers)
- Journals
- Carcinogenesis (4 papers)Science (2 papers)FEBS Letters (1 paper)British Journal of Cancer (1 paper)Nature (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
C.S. Cooper
16 papers receiving 913 citations
Peers
Comparison fields: 5 of 70
- Pulmonary and Respiratory Medicine 277
- Cancer Research 112
- Virology 33
- Oncology 132
- Pharmacology 49
Countries citing papers authored by C.S. Cooper
This map shows the geographic impact of C.S. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.S. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.S. Cooper more than expected).
Fields of papers citing papers by C.S. Cooper
This network shows the impact of papers produced by C.S. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.S. Cooper. The network helps show where C.S. Cooper may publish in the future.
Co-authors
The 25 scholars most cited alongside C.S. Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. | 1996 | 152 |
| 2 | 1989 | 150 | |
| 3 | Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. | 1989 | 138 |
| 4 | 1982 | 114 | |
| 5 | 1999 | 103 | |
| 6 | Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines. | 1984 | 94 |
| 7 | 1994 | 58 | |
| 8 | 1989 | 48 | |
| 9 | 1982 | 47 | |
| 10 | 1980 | 18 | |
| 11 | Detection of transforming genes by transfection of DNA from primary soft-tissue tumours. | 1991 | 17 |
| 12 | 2010 | 14 | |
| 13 | Molecular structure of (+/-)-7,8,9,10-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a)pyrene determined by x-ray crystallography. | 1982 | 13 |
| 14 | 1980 | 12 | |
| 15 | 1980 | 4 | |
| 16 | 1983 | 2 | |
| 17 | 2008 | 0 |
About C.S. Cooper
C.S. Cooper is a scholar working on Cancer Research, Oncology, Toxicology, Pharmacology and Inorganic Chemistry, having authored 17 papers that have together received 984 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (5 papers), Cancer-related Molecular Pathways (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Crystal structures of chemical compounds (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (277 citations), Cancer Research (112 citations), Virology (33 citations), Oncology (132 citations) and Pharmacology (49 citations). C.S. Cooper has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Michael R. Stratton, B.A. Gusterson, Cyril Fisher, Brian R. Reeves, Marianne K. Oskarsson, Peter L Lantos, John L. Darling, Sandra Gill, Gerlinde Pilkington and Graham H. Goodwin. Their work appears in journals such as Carcinogenesis, Science, FEBS Letters, British Journal of Cancer and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.